Transplant Matters

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Ahmet Kilic, MD
Margarita Camacho, MD, MBA, MS

Presentations

  1. Pre-Transplant Kidney Dysfunction in Heart Transplantation: How Low Can You Go?
    Asvin M. Ganapathi, MD
    Disclosure(s): Abbvie Pharmaceuticals: Consultant (Terminated, January 1, 2021)
     
  2. Center-level Variation in Allograft Rejection Following Heart Transplantation in the Modern Era
    Samuel T. Kim, BA
     
  3. Risk Factors for Mortality Following Heart Transplantation in Obese Patients Bridged with an LVAD
    Krishna Bhandari, MD
     
  4. Comparison of Intra-Aortic Balloon Pump and Impella 5.5 as Bridging Strategies to Heart Transplantation in the United States
    Amit Iyengar, MD, MS
     
  5. Maintaining Excellent Heart Transplant Outcomes: Is It Possible with Sicker Patients?
    Scott Silvestry, MD
     
  6. Panel Discussion
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Activity opens: 
02/01/2023
Activity expires: 
02/01/2026
Cost:
$0.00
Rating: 
0

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation

Price

Cost:
$0.00
Please login or register to take this course.

Unless otherwise noted, speakers have nothing to disclose.

Moderators

Ahmet Kilic, MD
Margarita Camacho, MD, MBA, MS

Presentations

  1. Pre-Transplant Kidney Dysfunction in Heart Transplantation: How Low Can You Go?
    Asvin M. Ganapathi, MD
    Disclosure(s): Abbvie Pharmaceuticals: Consultant (Terminated, January 1, 2021)
     
  2. Center-level Variation in Allograft Rejection Following Heart Transplantation in the Modern Era
    Samuel T. Kim, BA
     
  3. Risk Factors for Mortality Following Heart Transplantation in Obese Patients Bridged with an LVAD
    Krishna Bhandari, MD
     
  4. Comparison of Intra-Aortic Balloon Pump and Impella 5.5 as Bridging Strategies to Heart Transplantation in the United States
    Amit Iyengar, MD, MS
     
  5. Maintaining Excellent Heart Transplant Outcomes: Is It Possible with Sicker Patients?
    Scott Silvestry, MD
     
  6. Panel Discussion